Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
the Laboratory of Nano Particles at Empa and also matriculate in ETH Zürich. The research focuses on developing innovative plasmonic materials. Surface plasmon resonance (SPR) and localized surface
-
% of the cases occur in developing countries, and most of these cases would be preventable with appropriate treatment. We are therefore developing an optically transparent, engineered corneal transplant
-
, characterization and optimization of molecules with drug-like properties, and the development of novel therapeutic concepts. The group follows a highly integrated and multidisciplinary approach, including drug
-
. Empa is a research institution of the ETH Domain. Our group focusses on the development of carbon-based (thermo)electric nanoscale devices and their application for quantum technologies and energy
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
Your position Magnetic resonance imaging (MRI), developed in the early 1970s, offers exceptional soft tissue sensitivity and has powered the astounding progress of medicine over the past fifty years
-
career development are located in Basel. Basel provides a high standard of living and a rich and varied cultural atmosphere.
-
how perishable biological products react inside cold chain unit operations and to pinpoint why some products decay faster. For that purpose, we develop digital twins of the cargo, based on measured air
-
to muon g-2 from lattice Quantum Chromodynamics and algorithmic developments for multi-level and RG-improved simulations (research group of Urs Wenger) C.) Study of multi-hadron systems, with a focus on
-
Your position Our group conducts research at the intersection of artificial intelligence (AI) and pediatric healthcare, developing AI and machine learning (ML) methods to address real-world clinical